FOLUKE AKINOLA: Open Payments
NPI 1881352789 · MEDFORD, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,505 in 34 payments from 7 companies in 2025. Trend: 2023 $148 · 2024 $715 · 2025 $1,505
Food & beverage: $1,393Education: $111
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 13 | $667 |
| Teva Pharmaceuticals USA, Inc. | 6 | $229 |
| E.R. Squibb & Sons, L.L.C. | 4 | $211 |
| Otsuka America Pharmaceutical, Inc. | 3 | $166 |
| Lundbeck LLC | 6 | $159 |
| Janssen Pharmaceuticals, Inc | 1 | $43 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $28 |
Products named: ARISTADA, ABILIFY MAINTENA, COBENFY, LYBALVI, VIVITROL, UZEDY, ABILIFY ASIMTUFII, INVEGA SUSTENNA.
Industry payments across NY — which companies pay providers there.
